Royal Bank of Canada’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$511K Buy
262,026
+250,387
+2,151% +$488K ﹤0.01% 4127
2025
Q1
$20K Sell
11,639
-12,579
-52% -$21.6K ﹤0.01% 5545
2024
Q4
$65K Sell
24,218
-1,290
-5% -$3.46K ﹤0.01% 5085
2024
Q3
$58K Buy
25,508
+8,627
+51% +$19.6K ﹤0.01% 5168
2024
Q2
$49K Sell
16,881
-3,645
-18% -$10.6K ﹤0.01% 5282
2024
Q1
$75K Sell
20,526
-46,369
-69% -$169K ﹤0.01% 4911
2023
Q4
$101K Buy
66,895
+42,392
+173% +$64K ﹤0.01% 5083
2023
Q3
$33K Buy
24,503
+9,304
+61% +$12.5K ﹤0.01% 5497
2023
Q2
$27K Buy
15,199
+8,687
+133% +$15.4K ﹤0.01% 5603
2023
Q1
$11K Sell
6,512
-8,263
-56% -$14K ﹤0.01% 5881
2022
Q4
$28K Buy
14,775
+13,247
+867% +$25.1K ﹤0.01% 5693
2022
Q3
$3K Buy
1,528
+860
+129% +$1.69K ﹤0.01% 6415
2022
Q2
$2K Sell
668
-9,111
-93% -$27.3K ﹤0.01% 6510
2022
Q1
$51K Sell
9,779
-22,875
-70% -$119K ﹤0.01% 5595
2021
Q4
$277K Buy
32,654
+25,367
+348% +$215K ﹤0.01% 4503
2021
Q3
$73K Buy
7,287
+3,161
+77% +$31.7K ﹤0.01% 5414
2021
Q2
$39K Buy
+4,126
New +$39K ﹤0.01% 5705